TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CVS Health ( (CVS) ) has shared an announcement.
On November 20, 2025, CVS Health announced the appointment of J. David Joyner as Chair of the Board, effective January 1, 2026. Joyner, who became President and CEO in October 2024, has driven significant improvements in the company’s performance. The Board believes his leadership will help execute long-term strategies and create stockholder value. This move reflects CVS Health’s commitment to simplifying healthcare and delivering better health outcomes across the country.
The most recent analyst rating on (CVS) stock is a Buy with a $102.00 price target. To see the full list of analyst forecasts on CVS Health stock, see the CVS Stock Forecast page.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Outperform.
CVS Health’s overall stock score reflects strong earnings call performance and positive technical indicators, which are offset by moderate financial performance and valuation concerns. The company’s ability to manage profitability challenges and leverage will be crucial for future performance.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
CVS Health is a leading health solutions company with approximately 9,000 retail pharmacy locations, over 1,000 walk-in and primary care medical clinics, and a prominent pharmacy benefits manager serving around 87 million plan members. The company also provides health insurance products and services to over 37 million people, including Medicare Advantage and standalone Medicare Part D plans. CVS Health’s integrated model leverages personalized, technology-driven services to enhance access to quality care, improve outcomes, and reduce costs.
Average Trading Volume: 7,387,777
Technical Sentiment Signal: Buy
Current Market Cap: $97.18B
For detailed information about CVS stock, go to TipRanks’ Stock Analysis page.